Medtronic wins US appeal to overturn $106.5 mln heart-valve patent verdict A U.S. appeals court on Friday overturned a jury's verdict that medical device maker Medtronic owes competitor Colibri $106.5 ...

The CoreValve Evolut TAVR implant. [Image courtesy of Medtronic] Medtronic (NYSE:MDT) today announced five-year data that supports its CoreValve Evolut transcatheter aortic valve replacement (TAVR) ...

A transjugular intrahepatic portosystemic shunt (TIPS) procedure is a treatment method used to lower portal hypertension, or excessive pressure in your portal vein. This vein is responsible for ...

Coronary access following transcatheter aortic valve replacement for aortic stenosis can’t be achieved in nearly 8% of patients, with unsuccessful cannulation almost exclusive to those who received ...

Two registry studies have linked Edwards Lifesciences' transcatheter aortic valve replacement (TAVR) system to better outcomes than Medtronic's rival device. The studies, which were published in the ...

PARIS, France—High-risk patients with aortic stenosis undergoing transcatheter aortic valve replacement fare just as well when treated with either the balloon-expandable or self-expanding ...

SAN DIEGO -- Transfemoral transcatheter aortic valve replacement (TAVR) with the balloon-expandable Edwards Sapien 3 valve yields the same early outcomes as the self-expanding CoreValve Evolut R, ...

TAVI has become the standard treatment in patients at increased surgical risk and is increasingly being performed in patients at intermediate to low surgical risk. While non-inferiority has been ...

Patients implanted with the CoreValve transcatheter aortic valve replacement showed strong blood flow and improved quality of life at five years post-implant, according to results from two Medtronic ...

The results of two studies by Medtronic indicate improved outcomes at the five-year mark for patients implanted with the Dublin-based company’s CoreValve transcatheter aortic valve replacement device.

The extent to which pressure generated by the valve on the aortic root plays a role in the genesis of conduction abnormalities after transcatheter aortic valve replacement (TAVR) is unknown. This ...